Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: License List - Slightly different format - By Fiscal Year

<Unless the 10q reveals some kind of "business resolution" tied to the USPTO decision, the USPTO really shouldn't have that much bearing on the current market valuation of PTSC as PTSC has been able to>

Lamberts, with all due respect, first the market views things in a forward sense. Second, Forgent was a company signing companies, and involved in litigation until their patents were declared invalid. So to tell me the USTPO decision won't have that much bearing is IMO wrong. The USTPO decision forced Forgent to cease any further litigation for those patents.......


Mar 07, 2008 03:22AM
Share
New Message
Please login to post a reply